BridgeMD
New treatment option for COPD
Official title Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov ID: NCT06347536
What this study is testing
What is Supported rescue pack?
Supported rescue pack is an investigational medicine, given as an once-weekly pill taken by mouth, being studied as a potential treatment for copd.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Chronic obstructive pulmonary disease (COPD) is a chronic lung disease affecting approximately 10% of the adult population globally. COPD is recognised to be an important area of focus, as part of one of the healthcare challenges defined by the Office of Life Sciences.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Age ≥ 40 years
- Individuals admitted to hospital with COPD exacerbation who have recently been discharged (discharged from ongoing support from secondary care team...
- Ability to provide written informed consent
You likely can't join if
- Individuals who require invasive ventilation during the hospital admission
- Patients who have an expected survival of less than 90 days
- Patients with signs of new consolidation on chest X-ray (if available).
- Individuals who have been discharged to a residential or nursing home to residential or nursing home.
- Individuals who are unable to manage a supported self-management plan.
- Individuals with no access to telephone.
See the full eligibility criteria
- Age ≥ 40 years
- Individuals admitted to hospital with COPD exacerbation who have recently been discharged (discharged from ongoing support from secondary care team which includes hospital and virtual wards). Admission is defined as an...
- Ability to provide written informed consent
- Individuals who require invasive ventilation during the hospital admission
- Patients who have an expected survival of less than 90 days
- Patients with signs of new consolidation on chest X-ray (if available).
- Individuals who have been discharged to a residential or nursing home to residential or nursing home.
- Individuals who are unable to manage a supported self-management plan.
- Individuals with no access to telephone.
- Individuals who are already taking part in an treatment trial.
- Previous participation in the RAPID trial.
The study team makes the final eligibility decision.
Where it's taking place
- Barnsley, United Kingdom
- Birmingham, United Kingdom
- Blackpool, United Kingdom
- Bradford, United Kingdom
- Brighton, United Kingdom
- Bristol, United Kingdom
- Durham, United Kingdom
- Gateshead, United Kingdom
- Ipswich, United Kingdom
- Lancaster, United Kingdom
- Leicester, United Kingdom
- Llandough, United Kingdom
- London, United Kingdom
- Maidstone, United Kingdom
- Middlesbrough, United Kingdom
- Milton Keynes, United Kingdom
- Newcastle upon Tyne, United Kingdom
- Nottingham, United Kingdom
- Oxford, United Kingdom
- Rotherham, United Kingdom
+ 10 more site(s).
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barnsley, United Kingdom; Birmingham, United Kingdom; Blackpool, United Kingdom; Bradford, United Kingdom; Brighton, United Kingdom; Bristol, United Kingdom and 24 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.